Biomarkers and therapeutics targets
Search for publications
Only original articles, editorials, guidelines.
-
Franzese C, Tanadini-Lang S, Verellen D, Wiersema L, Hörner-Rieber J, Romero AM, Pasquier D, Bruynzeel A, Boda-Heggemann J, Depuydt T, Sibolt P, Douir N, Kuncman L, Beijst C, Stephens H, de la Pinta C, Cuccia F, Milder M, Nicosia L, Onishi H, Louie AV, Sahgal A, Lo SS, Slotman BJ, Guckenberger M, Scorsetti M.
Clinical practice, barriers to implementation, and priorities for equitable access of Stereotactic Body Radiation Therapy: An analysis of the global status by the ESTRO SBRT Focus Group.
Clinical And Translational Radiation Oncology . 57: 101096-101096.
-
Rodríguez-Serrano M, Martín-García E, Alonso-Andrés P, Conde-Moreno E, Pian H, Del Moral-Salmoral J, Alcharani N, Menacho-Román M, Crespo-Toro L, Ramos-Muñoz ME, Zaragoza C, Rincón LM, Barderas MG, García-Bermejo ML.
Dynamic microRNA Signatures as Biomarkers for Cardiac Ischemia and Remodeling.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 27(3): .
-
Castillo M, Casado-Gómez-Pallete J, Lázaro-Bailón J, Iniesta-Chamorro JM, García-Bermejo ML, Sancho S, Hernando ME, de la Pinta C.
Validation of a patient-based strategy for ambulatory monitoring of oncological pain by a mobile application.
SCIENTIFIC REPORTS . 16(1): 5404-5404.
-
Pistollato F, Furtmann F, Straccia M, Avey M, Azilagbetor DM, Camp C, Delaney C, Ferreira GS, Garcia-Bermejo ML, Gastaldello A, Gurusamy K, Holden L, Kimmelman J, Lohse S, Marigliani B, Menon JML, Ritskes-Hoitinga M, Sarasija S, Tagle D, Tripodi IJ, Turner J, Wehling M, Costantino H.
Evaluating the translational value of preclinical models: Available tools and frameworks, challenges and strategies.
ATLA-ALTERN LAB ANIM . 54(1): 10-27.
-
de la Pinta C, Domínguez A, Gallego Gasqué VM, Castillo ME, Fernández Martín P, Helguera A, Gómez Blasco P, de Los Santos G.
Survey to evaluate the usefulness of a clinical ethics committee service and analyze the most frequent ethical conflicts in clinical ethics consulting at the Ramon y Cajal University Hospital.
Revista clinica espanola . 225(10): 502390-502390.
-
Kuncman L, la Pinta C, Milder MTW, Romero AM, Guckenberger M, Franzese C, Scorsetti M, Bruc B, Verellen D, Tanadini-Lang S.
Definition and requirements for stereotactic radiotherapy: a systematic review
RADIOTHERAPY AND ONCOLOGY . 211: 111107-111107. Number of citations: 2
-
Xenophontos E, Giaj Levra N, Durieux V, van Geffen WH, Grisay G, De La Pinta Alonso C, Arasanz H, Prisciandaro E, Ferrara R, Derks J, Von der Thusen J, Dickhoff C, Brandão M, Faivre-Finn C, Edwards J, Ruysscher D, Remon J, Dingemans AC, Berghmans T.
Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group
Lung Cancer . 207: 108671-108671. Number of citations: 1
-
Audisio A, Gallio C, Velenik V, Meillat H, Ruiz-Garcia E, Riesco MC, Alecha JS, Rasschaert G, Carvalho C, Randrian V, Kirac I, Hernando J, Artaç M, O'Connor JM, Waldhorn I, Braam PM, Shamseddine A, Moretto R, de la Pinta C, De Felice F, Dulskas A, Páez López-Bravo D, Vanden Bulcke A, Bock F, Deleporte A, Van Den Eynde M, Geboes KP, Loi M, Messina M, Houlzé-Laroye C, Puccini A, Pastorino A, Papamichael D, Fiore M, Sur D, Eid M, Antoun C, Salati M, Garajovà I, Jakubauskas M, Tomášek J, Sousa Pinto CM, Schwingel J, Morano F, Adams RA, Dermine A, Chau A, Javed MA, Ghidini M, Fiorica F, Montenegro P, Petrillo A, Spolverato G, Mulet Margalef N, Diaz M, Baratelli C, Puleo F, Karampeazis A, Sert F, Gilliaux Q, De Stefano A, Liberale G, Moretti L, Martinive P, Deltuvaite Thomas V, Staggs V, Saad ED, Van Laethem JL, Sclafani F.
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
JAMA Oncology . 11(9): 1045-1054. Number of citations: 7
-
Paniagua-Iglesias P, Rincón-Ferrari MD, Candela-Toha A, Marcos-Jubilar M, Barquero-Lopez M, Gich-Saladich I, Medina-Marrero L, Bosch-Llobet A, Garrido-Fleischmann D, Ordoñez-Llanos J, Urrutia-Cuchí G.
Improving the Compliance of Massive Hemorrhage Protocols Through Education Is Associated with Patient Survival
Journal Of Clinical Medicine . 14(13): .
-
Bermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, Garcia-Osuna R, Linares T, Díaz M, Martín N, Barros X, Marco H, Navarro MI, Esparza N, Elias S, Coloma A, Roberto Robles N, Agraz I, Poch E, Rodas L, Lozano V, Fernández-Fernández B, Hernández E, Martínez MI, Stanescu RI, Moirón JP, García-Fernández N, Goicoechea M, Calero F, Bonet J, Liaño F, Pascual J, Praga M, Fulladosa X, Soler MJ.
A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study.
Nefrologia . 45(5): 360-368.
-
Ciérvide R, Manchón R, Ángel D, Quiles B, Rodríguez G, Veiras M, Blanco J, Diaz FM, Del Portillo EG, Monroy JL, Larrea L, Expósito J, Aristu J, Benavente S, Corrales-García E, Prieto C, García ME, Payano S, Perez MJ, Miguel IS, de la Pinta C, Díaz L, Mascias VM, Villarreal CLM, López M, Martínez FJ, Peña M, García R.
Stereotactic radiosurgery practice patterns for brain metastases: a survey by the SRS_SBRT_SEOR (Spanish Society of Radiation Oncology) Working Group
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY . 30(4): 513-522.
-
Hewitt E, Bouche G, Alencar AC, Bigelsen SJ, Radu R, Stoyanova-Beninska V, Carrato A, Valsecchi F, Soler Cantón A, van der Meer HG, García Bermejo ML, Budillon A, Cardone L, Rooman I, Platteeuw H, Baijet J, Fuchs C.
Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients
Cancer Management And Research . 17: 429-440. Number of citations: 1
-
Bara-Ledesma N, Viteri-Noel A, Lopez Rodriguez M, Stamatakis K, Fabregate M, Vazquez-Santos A, Gomez Del Olmo V.
Advances in Gene Therapy for Rare Diseases: Targeting Functional Haploinsufficiency Through AAV and mRNA Approaches
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 26(2): . Number of citations: 11
-
Piredda R, Martínez LGR, Stamatakis K, Martinez-Ortega J, Ferráz AL, Almendral JM, Revilla Y.
Assessment of molecular modulation by multifrequency electromagnetic pulses to preferably eradicate tumorigenic cells.
SCIENTIFIC REPORTS . 14(1): 30150-30150.
-
González-Lafuente L, Mercado-García E, Vázquez-Sánchez S, González-Moreno D, Boscá L, Fernández-Velasco M, Segura J, Kuro-O M, Ruilope LM, Liaño F, Ruiz-Hurtado G.
Interleukin-6 as a prognostic marker in acute kidney injury and its klotho-dependent regulation.
Nefrologia . 44(6): 818-829.
-
Gonzalez-Lafuente, Laura, Mercado-Garcia, Elisa, Vazquez-Sanchez, Sara, Gonzalez-Moreno, Daniel, Bosca, Lisardo, Fernandez-Velasco, Maria, Segura, Julian, Kuro-O, Makoto, Ruilope, Luis M., Liano, Fernando, Ruiz-Hurtado, Gema.
Interleukin-6 as a prognostic marker in acute renal injury and its klotho-dependent regulation
NEFROLOGIA . 44(6): 818-829.
-
Budillon A, Leone A, Passaro E, Silvestro L, Foschini F, Iannelli F, Roca MS, Macchini M, Bruzzese F, Garcia Bermejo ML, Rodriguez Garrote M, Tortora G, Milella M, Reni M, Fuchs C, Hewitt E, Kubiak C, Di Gennaro E, Giannarelli D, Avallone A.
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol.
Bmc Cancer . 24(1): 1167-1167.
-
Hernando-Requejo O, Olombrada MVT, Bravo IA, Moreno LA, López-Campos F, Gonzalez ML, Martín MM, Macías VM, de la Pinta C.
Current landscape of gastrointestinal radiation oncology in Spain: a multicenter real-life survey and comparison with key clinical guidelines.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY . 29(3): 340-347.